Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Meta-analysis highlights most effective treatments for normal tension glaucoma
  • Glaucoma

Meta-analysis highlights most effective treatments for normal tension glaucoma

Kelsey Moroz

A recent systematic review and network meta-analysis compared the long-term effectiveness of various treatments for normal tension glaucoma in controlling intraocular pressure (IOP).

The study evaluated data from 795 patients (997 eyes) across randomized controlled trials, focusing on treatments with a duration of >12 weeks. Eight medications, including topical agents and an oral drug, were assessed.

Palmitoylethanolamide, an oral treatment, demonstrated the highest efficacy for long-term IOP control. It was followed by the prostaglandin analogues travoprost and latanoprost, and the beta-blockers nipradilol and timolol. Medications such as brimonidine, unoprostone isopropyl, and brovincamine showed more limited effectiveness.

The study suggests Palmitoylethanolamide, could be a valuable option for patients with normal tension glaucoma, either as a primary or adjunctive treatment.

Reference
Yang TK, Kuo HT, Ju YJ, et al. Comparative analysis of medical treatments for long-term control of normal tension glaucoma: A systematic review and model-based network meta-analysis. Clin Exp Ophthalmol. 2024;doi: 10.1111/ceo.14447. Epub ahead of print. PMID: 39385332.

Share

Related Content

  • Glaucoma

Large wearable study examines physical activity and sleep in adults with glaucoma

  • Glaucoma

Optometrists expand role in glaucoma care worldwide, but barriers remain

  • Glaucoma

Global glaucoma disability rates decline despite rising case burden

  • Glaucoma

Adults with ASD show higher rates of glaucoma, cataract, and other eye conditions

  • Glaucoma

Cognitive function and comorbidity linked to different glaucoma medication adherence barriers

  • Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon